ArticleJournal of clinical hypertension (Greenwich, Conn.)2026
Office Blood Pressure and Arteriolosclerosis in Biopsy-Proven Glomerulonephritis: Association With Renal Function Decline and Clinical Outcomes.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is a major determinant of chronic kidney disease progression, yet the relationship between standardized office blood pressure measurements (OBPM), chronic vascular lesions, and prognosis in biopsy-proven glomerulonephritis (GN) remains poorly defined. We investigated the association between OBPM and renal histopathological lesions, focusing on arteriolosclerosis, and assessed their prognostic significance. This retrospective longitudinal study included 66 adults with biopsy-proven GN. All patients underwent standardized OBPM, laboratory evaluation, and renal biopsy. Histopathological assessment included glomerular, vascular, tubular, and interstitial lesions. Patients were followed for 36 months. Mixed-effects models evaluated longitudinal changes in blood pressure, proteinuria, and estimated glomerular filtration rate (eGFR), while logistic regression identified predictors of renal and cardiovascular outcomes. Patients with arteriolosclerosis had significantly higher systolic blood pressure (SBP) than those without (130 vs. 120 mmHg, p = 0.032). SBP > 130 mmHg was associated with arteriolosclerosis (p = 0.004), arterial intimal fibrosis (p = 0.005), crescentic lesions (p = 0.033), and glomerulosclerotic changes (p = 0.048), whereas no associations were observed for diastolic blood pressure (DBP). During follow-up, proteinuria significantly decreased (p < 0.001), whereas SBP remained stable. Arteriolosclerosis was associated with a steeper decline in eGFR over time (interaction β = -4.91 mL/min/1.73 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.